| Acronym |
Study |
Country |
| BCFR
| Breast Cancer Family Registry
| USA/Australia/Canada
|
| BFBOCC
| Baltic Familial Breast Ovarian Cancer Consortium
| Latvia/Lithuania
|
| BMBSA
| BRCA-gene mutations and breast cancer in South African women
| South Africa
|
| BRICOH
| Beckman Research Institute of the City of Hope
| USA
|
| CBCS
| Rigshospitalet
| Denmark
|
| CNIO
| Spanish National Cancer Centre
| Spain
|
| COH
| City of Hope Cancer Center
| USA
|
| CONSIT TEAM
| CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella
| Italy
|
| DKFZ
| German Cancer Research Center
| Germany/Pakistan/Colombia
|
| DNA HEBON
| Genen Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland
| Netherlands
|
| EMBRACE
| Epidemiological Study of Familial Breast Cancer
| UK
|
| FCCC
| Fox Chase Cancer Center
| USA
|
| GC-HBOC
| German Familial Breast Group
| Germany
|
| GEMO
| Genetic Modifiers of cancer risk in BRCA1/2 mutation carriers
| France/USA
|
| GEORGETOWN
| Georgetown University
| USA
|
| GOG
| Gynecologic Oncology Group
| USA
|
| HCSC
| Hospital Clinico San Carlos
| Spain
|
| HEBCS
| Helsinki Breast Cancer Study
| Finland
|
| HRBCP
| Study of Genetic Mutations in Breast and Ovarian Cancer patients in Hong Kong and Asia
| Hong Kong
|
| HUNBOCS
| Molecular Genetic Studies of Breast- and Ovarian Cancer in Hungary
| Hungary
|
| HVH
| University Hospital Vall d'Hebron
| Spain
|
| ICO
| Institut Català d'Oncologia
| Spain
|
| IHCC
| International Hereditary Cancer Centre
| Poland
|
| ILUH
| Iceland Landspitali - University Hospital
| Iceland
|
| INHERIT
| INterdisciplinary HEalth Research Internal Team BReast CAncer susceptibility
| Canada (Quebec)
|
| IOVHBOCS
| Istituto Oncologico Veneto
| Italy
|
| IPOBCS
| Portuguese Oncology Institute-Porto Breast Cancer Study
| Portugal
|
| KCONFAB
| Kathleen Cuningham Consortium for Research into Familial Breast Cancer
| Australia/New Zealand
|
| KOHBRA
| Korean Hereditary Breast Cancer Study
| Korea
|
| MAGIC
| Modifiers and Genetics in Cancer
| USA
|
| MCGILL
| McGill University
| Canada (Quebec)
|
| MAYO
| Mayo Clinic
| USA
|
| MOD SQUAD
| Modifier Study of Quantitative Effects on Disease
| Czech Republic/Belgium
|
| MSKCC
| Memorial Sloane Kettering Cancer Center
| USA
|
| MUV
| General Hospital Vienna
| Austria
|
| NCI
| National Cancer Institute
| USA
|
| NICCC
| National Israeli Cancer Control Center
| Israel
|
| NNPIO
| N.N. Petrov Institute of Oncology
| Russia
|
| OCGN
| Ontario Cancer Genetics Network
| Canada
|
| OSU CCG
| The Ohio State University Comprehensive Cancer Center
| USA
|
| OUH
| Odense University Hospital
| Denmark
|
| PBCS
| Università di Pisa
| Italy
|
| SEABASS
| South East Asian Breast Cancer Association Study
| Malaysia/Singapore
|
| SMC
| Sheba Medical Centre
| Israel
|
| SWE-BRCA
| Swedish Breast Cancer Study
| Sweden
|
| UCLA
| University of California Los Angeles
| USA
|
| UCSF
| University of California San Francisco
| USA
|
| UKGRFOCR
| UK and Gilda Radner Familial Ovarian Cancer Registries
| UK/USA
|
| UPENN
| University of Pennsylvania
| USA
|
| VFCTG
| Victorian Familial Cancer Trials Group
| Australia
|
| WCRI
| Women's Cancer Program at Cedars-Sinai Medical Center
| USA
|
